Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
The closing price of Doximity Inc (NYSE: DOCS) was $64.13 for the day, down -0.36% from the previous closing price of $64.36. In other words, the price has decreased by -$0.36 from its previous closing price. On the day, 0.94 million shares were traded. DOCS stock price reached its highest trading level at $64.92 during the session, while it also had its lowest trading level at $63.69.
Ratios:
Our analysis of DOCS’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.29 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 41.83. For the most recent quarter (mrq), Quick Ratio is recorded 6.44 and its Current Ratio is at 6.44. In the meantime, Its Debt-to-Equity ratio is 0.01 whereas as Long-Term Debt/Eq ratio is at 0.01.
On June 02, 2025, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $80.
Piper Sandler Upgraded its Neutral to Overweight on February 07, 2025, whereas the target price for the stock was revised from $31 to $78.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Aug 15 ’25 when Cabral Timothy S sold 20,000 shares for $63.78 per share. The transaction valued at 1,275,566 led to the insider holds 6,360 shares of the business.
TIMOTHY CABRAL bought 20,000 shares of DOCS for $1,275,566 on Aug 15 ’25. On Aug 08 ’25, another insider, Benjamin Regina M., who serves as the Director of the company, sold 5,000 shares for $63.00 each. As a result, the insider received 315,000 and left with 16,618 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DOCS now has a Market Capitalization of 12011485184 and an Enterprise Value of 11182382080. As of this moment, Doximity’s Price-to-Earnings (P/E) ratio for their current fiscal year is 55.05, and their Forward P/E ratio for the next fiscal year is 38.52. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 5.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 20.38 while its Price-to-Book (P/B) ratio in mrq is 11.72. Its current Enterprise Value per Revenue stands at 18.965 whereas that against EBITDA is 45.847.
Stock Price History:
The Beta on a monthly basis for DOCS is 1.36, which has changed by 0.756505 over the last 52 weeks, in comparison to a change of 0.13054323 over the same period for the S&P500. Over the past 52 weeks, DOCS has reached a high of $85.21, while it has fallen to a 52-week low of $35.32. The 50-Day Moving Average of the stock is 6.06%, while the 200-Day Moving Average is calculated to be 9.98%.
Shares Statistics:
DOCS traded an average of 1.92M shares per day over the past three months and 2007180 shares per day over the past ten days. A total of 136.53M shares are outstanding, with a floating share count of 132.38M. Insiders hold about 29.37% of the company’s shares, while institutions hold 65.59% stake in the company. Shares short for DOCS as of 1753920000 were 4067751 with a Short Ratio of 2.12, compared to 1751241600 on 5750839. Therefore, it implies a Short% of Shares Outstanding of 4067751 and a Short% of Float of 3.05.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Currently, 16.0 analysts are dedicated to thoroughly evaluating and rating the performance of Doximity Inc (DOCS) in the stock market.The consensus estimate for the next quarter is $0.45, with high estimates of $0.49 and low estimates of $0.39.
Analysts are recommending an EPS of between $1.62 and $1.35 for the fiscal current year, implying an average EPS of $1.51. EPS for the following year is $1.67, with 17.0 analysts recommending between $1.89 and $1.47.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 17 analysts. It ranges from a high estimate of $158M to a low estimate of $152.7M. As of the current estimate, Doximity Inc’s year-ago sales were $136.83MFor the next quarter, 17 analysts are estimating revenue of $180.09M. There is a high estimate of $183.86M for the next quarter, whereas the lowest estimate is $170.24M.
A total of 19 analysts have provided revenue estimates for DOCS’s current fiscal year. The highest revenue estimate was $640M, while the lowest revenue estimate was $625M, resulting in an average revenue estimate of $633.79M. In the same quarter a year ago, actual revenue was $570.4MBased on 19 analysts’ estimates, the company’s revenue will be $702.9M in the next fiscal year. The high estimate is $721.4M and the low estimate is $688.4M.
